References
- US FDA. Drugs. Procedural. Guidance for industry. Formal meetings between the FDA and sponsors or applicants. 2009. Available from: www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM153222.pdf
- European Medicines Agency. Regulatory. Scientific advice and protocol assistance. Available from: www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000049.jsp&mid=WC0b01ac05800229b9
- Frønsdal KB, Pichler F, Mardhani-Bayne L, et al. Interaction initiatives between regulatory, health technology assessment and coverage bodies, and industry. Int J Technol Assess Health Care 2012;28(4):374-814
- Backhouse M, Wonder M, Hornby E, et al. Early dialogue between the developers of new technologies and pricing and reimbursement agencies. A pilot study. Value Health 2011;14(4):608-15
- National Institute for Health and Care Excellence (NICE). NICE Scientific Advice. Available from: www.nice.org.uk/aboutnice/scientificadvice/AboutScientificAdvice.jsp
- Phillips S, Crowe E, Chivers R, Longson C. Three years of NICE. Scientific advice; comprehensive analysis of requests to the programme. Value Health 2012;15(7):A278
- Wonder M, Backhouse M, Hornby E. Early scientific advice obtained simultaneously from regulators and payers: findings from a pilot study in Australia. Value Health 2013;16(6):1067-73
- National Institute for Health and Care Excellence. NICE Scientific Advice. Advice alongside the regulators. Available from: http://www.nice.org.uk/aboutnice/scientificadvice/AdviceAlongsideTheRegulators.jsp
- Tapestry Networks. Healthcare. Multi-stakeholder consultations in drug development. Available from: www.tapestrynetworks.com/issues/healthcare/multi-stakeholder-consultations-in-drug-development.cfm
- US FDA. News and events. Newsroom. Press announcements. FDA news release. FDA and European Medicines Agency launch generic drug application inspections initiative. 2013. Available from: www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm379031.htm
- European Network for Health Technology Assessment (EUnetHTA). EUnetHTA Joint Action 2 (2012-2015). General Objectives. Available from: www.eunethta.eu/activities/EUnetHTA%20Joint%20Action%202%20%282012-15%29/eunethta-joint-action-2-2012-2015
- EMA. European Medicines Agency/ health-technology-assessment-body workshop on parallel scientific advice in drug development. Available from: www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/events/2013/06/event_detail_000721.jsp&mid=WC0b01ac058004d5c3
- Elvidge S. EMA’s parallel advice workshop bridges regulatory and reimbursement divide. Nat Rev Drug Discov 2014;13(1):8
- International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Available from: www.ich.org
- Green Park Collaborative. Alzheimer’s disease pilot. Available from: www.greenparkcollaborative.org/alzheimers-disease-pilot/